<PAGE> 1
EXHIBIT A
ITEM 2 (ADDITIONAL INFORMATION):
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF GENENTECH, INC.
<TABLE>
<CAPTION>
NAME PRESENT PRINCIPAL OCCUPATION
---- ----------------------------
<S> <C>
EXECUTIVE OFFICERS
William R. Arathoon, Ph.D. Vice President, Process Sciences and Manufacturing
Joffre B. Baker, Ph.D. Vice President, Research Discovery
J. Joseph Barta Vice President, Quality
Stephen G. Dilly, M. D., Ph.D. Vice President, Medical Affairs
David Ebersman Vice President, Product Development
Robert L. Garnick, Ph.D. Vice President, Regulatory Affairs
Susan D. Desmond-Hellmann, M.D., M.P.H. Executive Vice President, Development and Product Operations and Chief Medical Officer
Roy C. Hardiman Vice President, Corporate Law
Dennis J. Henner, Ph.D. Senior Vice President, Research
Judith A. Heyboer Senior Vice President, Human Resources
Paula M. Jardieu, Ph.D. Vice President, Pharmacological Sciences
Sean A. Johnston, Ph.D. Vice President, Intellectual Property
Stephen G. Juelsgaard Senior Vice President, General Counsel and Secretary
R. Guy Kraines Vice President, Finance
Louis J. Lavigne, Jr. Executive Vice President and Chief Financial Officer
Laura Leber Vice President, Corporate Communications
Arthur D. Levinson, Ph.D. Director, Chairman, President and Chief Executive Officer
Walter K. Moore Vice President, Government Affairs
James P. Panek Senior Vice President, Product Operations
Diane L. Parks Vice President, Marketing
Kimberly J. Popovits Vice President, Sales
Myrtle S. Potter Executive Vice President, Commercial Operations and Chief Operating Officer
Andrew Scherer Vice President, Facilities and Engineering
Daniel S. Sulzbach, Ph.D. Vice President, Information Resources
John M. Whiting Controller and Chief Accounting Officer
DIRECTORS
Herbert W. Boyer, Ph.D. Director of Genentech, Inc.
Franz B. Humer, Ph.D. Chief Executive Officer of Roche Holding Ltd and Head of the Pharmaceuticals Division
of Roche Holding Ltd
Jonathan K. C. Knowles, Ph.D. President of Global Research of F. Hoffmann-La Roche Holding Ltd
Sir Mark Richmond Ph.D. Senior Research Fellow at the School of Public Policy, University College London
Charles Sanders, M.D. Director of Genentech, Inc.
MAILING ADDRESS FOR ALL
EXECUTIVE OFFICERS AND DIRECTORS: 1 DNA Way
South San Francisco, CA 94080-4990
</TABLE>
During the last five years: (i) none of the individuals described above has been
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors); and (ii) none of the individuals described above has been a party
to a civil proceeding of a judicial or administrative body of competent
jurisdiction which as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws. Each of the individuals listed above is
a U.S. citizen, except Dr. Humer who is a citizen of Switzerland, Dr. Knowles
who is a citizen of England and Sir Richmond who is a citizen of the United
Kingdom.
